Article
Aptamer-Protamine-siRNA Nanoparticles in Targeted Therapy of ErbB3 Positive Breast Cancer Cells
2020-07-17
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>RNAi-based technology has achieved good results in both <italic>in vitro</italic> and <italic>in vivo </italic>applications, and it is expected to become a good genetic treatment for some diseases, especially neoplastic diseases. But there are still many obstacles in the <italic>in vivo</italic> application, the most important thing is the lack of an efficient a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 66e54aae-1402-5b17-bcec-86ad3a66e8c0
- DOI
- 10.21203/rs.3.rs-42522/v1
